Biotech Values

[DFRAI]

Poorgradstudent
i think that your scenario is the most correct. The 60 million (seems to be MNTA share, went back to check)and it will get deducted after cogs. We still will show a nice profit which will increase next quarter by about 30MM for a total of 75MM which should come to about 1.5/share/quarter (could be less depending on inventory...)

Just wonder when this teva hangover will be lifted and the wall street machine will take the stock up greatly - scenarios

1. Teva looses copaxone suit
2. FOB partnership
3. M118 partnership